Type 1 Diabetes Efficacy Studies

A New MHC Class I & II Deficient Platform Humanized With PBMC Has Delayed Xenogeneic GvHD

You save (%)

Select Options

Imiquimod Induced Psoriasis Efficacy Studies

You save (%)

Select Options

Lupus Efficacy Studies

You save (%)

Select Options

Studying CRS In A Diverse Population FAQS

You save (%)

Select Options

Targeting Natural Killer Cell Activity With Humanized NSG IL15 Mouse Model

You save (%)

Select Options

Comprehensive Immunodeficient Suite

You save (%)

Select Options

In Vivo Safety and Efficacy Platform for Immunotherapies

You save (%)

Select Options

In Vivo Evaluation Of Bispecific T-Cell Engager Efficacy & Safety

You save (%)

Select Options